What is MDNC's health score?

Medinotec Inc. (MDNC) has a TradeApes health score of 67 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MDNC's estimated fair value?

Based on our 5-year discounted cash flow model, Medinotec Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is MDNC undervalued or overvalued?

Our model currently rates MDNC as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MDNC... Refresh in a moment for the full analysis.

Medinotec Inc. (MDNC)

Healthcare Inconclusive inconclusive healthy

$5.0

Updated: 2026-06-05

TradeApes Score

Financial Strength

90 Strong

Operating Trend

58 Mixed

Relative Value

50 Mixed

Capital Allocation

60 Healthy

Risk

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Revenue declining — sales down 5–15% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.